Filing Details
- Accession Number:
- 0001127602-18-007417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-20 21:26:15
- Reporting Period:
- 2018-02-15
- Accepted Time:
- 2018-02-20 21:26:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1707477 | Mark Oene Van | 5200 Illumina Way San Diego CA 92122 | Svp Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-15 | 2,124 | $0.00 | 15,760 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-15 | 735 | $229.13 | 15,025 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-02-16 | 1,408 | $228.85 | 13,617 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Performance Shares | Disposition | 2018-02-15 | 2,124 | $0.00 | 2,124 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-12-31 | No | 4 | M | Direct |
Footnotes
- Each performance stock unit represented a contingent right to receive a share of Illumina common stock based upon the Company's achievement of certain earnings per share targets as of the three-year period ended December 31, 2017.
- The sale was made pursuant to a 10b5-1 plan.
- Balance includes 155 shares acquired through Employee Stock Purchase Plan.
- 88 performance stock units expired not having vested.
Billionaire Hedge Funds
